Interview with Neil Boyle, Managing Director, MSD Ireland (Human Health) Ltd
In 2010, you gave a lecture for the Great Place to Work Institute, and spoke about how you have navigated the change and rapid growth MSD Ireland has experienced in…
MSD, known as Merck in the United States and Canada, has operations in more than 140 countries. In Ireland, MSD employs approximately 2,000 people across its five locations in Dublin, Carlow, Cork, Tipperary and Wicklow. Its extensive Irish operations encompass manufacturing, commercial and marketing facilities. MSD is a leader in healthcare, dedicated to helping the world be well through a wide range of innovative health solutions. This includes the development, production and distribution of prescription medicines, vaccines and biologic therapies as well as animal health products. MSD’s commitment to research and to increasing access to healthcare across the world is demonstrated by clearly focused policies, far-reaching programmes and life-enhancing partnerships.
We are committed to improving health and wellbeing around the world. From developing new therapies that treat and prevent disease to helping people in need, we are guided by a rich legacy and inspired by a shared vision.
Address: MSD Human Health
Red Oak North
South County Business Park
Leopardstown, Dublin 18
Tel.: +353 1 299 8700
Website: http://www.msd-ireland.com/
Email: info_ireland@merck.com
In 2010, you gave a lecture for the Great Place to Work Institute, and spoke about how you have navigated the change and rapid growth MSD Ireland has experienced in…
Recent announcements from Ipsen and AbbVie of multimillion Euro investments into Irish manufacturing plants underline the Celtic nation’s continuing attractiveness to pharma multinationals. While an upcoming hike in Ireland’s famously…
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million manufacturing investment; and a new report on…
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key priorities of their exciting new Mercury 2021 strategy, the rationale behind their transition into…
David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life Sciences at Agility, discuss the company’s increased commitment to Ireland, their ongoing…
Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market, and more broadly in Ireland, during her extensive career at PwC.…
These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with increasing global demand for its products. “Sales from…
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s…
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory solutions, discusses the changes that the Irish healthcare system is going through, and how they…
Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help the pharmaceutical industry increase efficiency and save costs through their agile,…
Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly in North America, across both their Sharp and Ashfield business units. He also expands on…
Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve years, their comprehensive pain portfolio, the innovation they are bringing as pain specialists to…
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles…
See our Cookie Privacy Policy Here
